Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47
Smolen, Josef S, Trefler, Jakub, Racewicz, Artur, Jaworski, Janusz, Zielińska, Agnieszka, Krogulec, Marek, Jeka, Sławomir, Wojciechowski, Rafał, Kolossa, Katarzyna, Dudek, Anna, Krajewska-Włodarczyk, Magdalena, Hrycaj, Paweł, Klimiuk, Piotr Adrian, Burmester, Gerd R, Kim, SungHyun, Bae, YunJu, Yang, GoEun, Jung, YooBin, Hong, JiWoo, Keystone, Edward
Published in Rheumatic & musculoskeletal diseases open (18.10.2024)
Published in Rheumatic & musculoskeletal diseases open (18.10.2024)
Get full text
Journal Article
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Delmas, Pierre D, McClung, Michael R, Zanchetta, José R, Racewicz, Artur, Roux, Christian, Benhamou, Claude-Laurent, Man, Zulema, Eusebio, Rachelle A, Beary, John F, Burgio, David E, Matzkin, Ellen, Boonen, Steven
Published in Bone (New York, N.Y.) (01.01.2008)
Published in Bone (New York, N.Y.) (01.01.2008)
Get full text
Journal Article
Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study
Ste-Marie, Louis-Georges, MD, Brown, Jacques P., MD, Beary, John F., MD, Matzkin, Ellen, MD, Darbie, Lynn M., MS, Burgio, David E., PhD, Racewicz, Artur J., MD
Published in Clinical therapeutics (01.02.2009)
Published in Clinical therapeutics (01.02.2009)
Get full text
Journal Article
Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study
Racewicz, Artur J., Schofield, Pamela J., Cahall, David L., Cline, Gary A., Burgio, David E.
Published in Current medical research and opinion (01.12.2007)
Published in Current medical research and opinion (01.12.2007)
Get full text
Journal Article
Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty-Two-Week Phase III Randomized Study Results
Weinblatt, Michael E, Baranauskaite, Asta, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz-Rosiak, Krystyna, Baek, Inyoung, Ghil, Jeehoon
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.06.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.06.2018)
Get full text
Journal Article
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
Emery, Paul, Fleischmann, Roy, Filipowicz‐Sosnowska, Anna, Schechtman, Joy, Szczepanski, Leszek, Kavanaugh, Arthur, Racewicz, Artur J., van Vollenhoven, Ronald F., Li, Nicole F., Agarwal, Sunil, Hessey, Eva W., Shaw, Timothy M.
Published in Arthritis and rheumatism (01.05.2006)
Published in Arthritis and rheumatism (01.05.2006)
Get full text
Journal Article
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study
Yoo, Dae Hyun, Racewicz, Artur, Brzezicki, Jan, Yatsyshyn, Roman, Arteaga, Edgardo Tobias, Baranauskaite, Asta, Abud-Mendoza, Carlos, Navarra, Sandra, Kadinov, Vladimir, Sariego, Irmgadt Goecke, Hong, Seung Suh, Lee, Sung Young, Park, Won
Published in Arthritis research & therapy (02.04.2016)
Published in Arthritis research & therapy (02.04.2016)
Get full text
Journal Article
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Deodhar, Atul, Gottlieb, Alice B, Boehncke, Wolf-Henning, Dong, Bin, Wang, Yuhua, Zhuang, Yanli, Barchuk, William, Xu, Xie L, Hsia, Elizabeth C, AELION, Jacob, AMARELO-RAMOS, Juan, BALSA, Alejandro, BERGHEA, Florian, BRZEZICKI, Jan, BURNETTE, Michael, FRETZIN, Scott, GARCÍA-CARAZO, Sara, GLADSTEIN, Geoffrey, GOMEZ-REINO, Juan, GOODERHAM, Melinda, GONZÁLEZ-FERNÁNDEZ, Carlos, GOTTLIEB, Alice, GRATACOS, Jordi, HAALAND, Derek, KAMALOVA, Rima, LESZCZYNSKI, Piotr, MARTIN-MOLA, Emilio, MASLYANSKY, Alexey, NAVARRO, Federico, OPRIS, Daniela, PAPP, Kim, PERLAMUTROV, Yuriy, PHILIPP, Sandra, RACEWICZ, Artur, REBROV, Andrey, RELL-BAKALARSKA, Maria, ROSMARIN, David, RUBBERT-ROTH, Andrea, SHERGY, William, SHIRINSKY, Ivan, SONIN, Dmitry, STANISLAV, Marina, SUKHAREV, Alexey, TEMNIKOV, Vadim, VINOGRADOVA, Irina, WAYTZ, Paul, YAKUSHEVICH, Vladimir
Published in The Lancet (British edition) (02.06.2018)
Published in The Lancet (British edition) (02.06.2018)
Get full text
Journal Article
Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis
Weinblatt, Michael E., Baranauskaite, Asta, Niebrzydowski, Jaroslaw, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz‐Rosiak, Krystyna, Cheong, Soo Yeon, Ghil, Jeehoon, Sokolovic, S., Mekic, M., Prodanovic, N., Gajic, B., Karaselimovic‐Dzambasovic, E., Pojskic, B., Toncheva, A., Dimitar, P., Rodina, L., Geneva‐Popova, M., Staykov, I., Stoilov, R., Podrazilova, L., Mosterova, Z., Simkova, G., Kopackova, J., Stejfova, Z., Vencovsky, J., Urbanova, Z., Janska, L., Galatíkova, D., Stropuviene, S., Sniuoliene, I., Sitek‐Ziolkowska, K., Rell‐Bakalarska, M., Kolasa, R., Daniluk, S., Sliwowska, B., Bartosik‐Twardowska, M., Brzezicki, J., Konieczny, M., Jeka, S., Choe, J., Bae, S., Kang, Y., Prystupa, L., Vyacheslav, Z., Gasanov, I., Yatsyshyn, R., Rekalov, D., Iaremenko, O., Stanislavchuk, M., Tseluyko, V.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2018)
Get full text
Journal Article
Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis
Weinblatt, Michael E., Baranauskaite, Asta, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz‐Rosiak, Krystyna, Baek, Inyoung, Ghil, Jeehoon
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.06.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.06.2018)
Get full text
Journal Article
Phase III Randomized Study of SB 5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis
Weinblatt, Michael E., Baranauskaite, Asta, Niebrzydowski, Jaroslaw, Dokoupilova, Eva, Zielinska, Agnieszka, Jaworski, Janusz, Racewicz, Artur, Pileckyte, Margarita, Jedrychowicz‐Rosiak, Krystyna, Cheong, Soo Yeon, Ghil, Jeehoon
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2018)
Get full text
Journal Article